✨ Free AI Report
The Oncology Institute, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research The Oncology Institute, Inc.
Company Research

The Oncology Institute, Inc.: Business Overview, Financials & Competitive Analysis

The Oncology Institute, Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). TOI is well-positioned in the value-based oncology market with potential for margin expansion through scale and asset-light delegation models. TOI anticipates 2026 revenue of $630-650 million, reflecting 28% growth and demonstrating strong market traction. The company is approaching profitability with 2026 expected to be its first full year.

What is The Oncology Institute, Inc.'s industry? The Oncology Institute, Inc. (theoncologyinstitute.com) operates in Healthcare Services - Specialty Oncology / Value-Based Cancer Care. AskCyborg classifies The Oncology Institute, Inc. under Healthcare Services - Specialty Oncology / Value-Based Cancer Care in its company registry.

The Oncology Institute (NASDAQ: TOI), founded in 2007, is advancing oncology by delivering highly specialized, value-based cancer care in the community setting, offering cutting-edge, evidence-based cancer care to a p...

7/ 10Strong

Cyborg Score thesis

TOI is well-positioned in the value-based oncology market with potential for margin expansion through scale and asset-light...

Read the full analyst-debate transcript →
Industry Healthcare Services - Specialty Oncology / Value-Based Cancer Care
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest The Oncology Institute, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for The Oncology Institute, Inc.

AskCyborg analysts argue the bull and bear cases for The Oncology Institute, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
The Oncology Institute, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

The Oncology Institute, Inc. Overview

Pro stress-test →

The Oncology Institute (NASDAQ: TOI), founded in 2007, is advancing oncology by delivering highly specialized, value-based cancer care in the community setting, offering cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is transforming community-based oncology delivery.

Strategic Profile

Pro stress-test →

TOI is positioned for growth through 2028 with a target of ~20% annual revenue growth, driven by the migration toward comprehensive oncology care in a value-based landscape. 2026 is expected to represent TOI's first full year of Adjusted EBITDA profitability as a public company.

Competitive Landscape

Pro stress-test →

TOI is one of the largest value-based oncology groups in the United States. The company competes in the community-based oncology market with a focus on value-based contracting, capitation, and integrated care delivery. Competitors include larger healthcare systems and specialized oncology networks transitioning to value-based models.

Industry Context

The Oncology Institute, Inc. operates in Healthcare Services - Specialty Oncology / Value-Based Cancer Care.

Key facts

Founded: 2007 · Headquarters: Cerritos, US · Employees: 180+ clinicians + support staff · Revenue: $630-650M (2026 guidance) · Market cap: $356M

What the analysts stress-tested

The top findings that survived the multi-agent debate for The Oncology Institute, Inc..

  • 2026 revenue guidance of $630-650M represents 28% YoY growth, with ~$150M from capitation revenue.
  • TOI deployed a near-touchless prior authorization workflow with >80% reduction in office-visit authorization submission time, freeing hundreds of staff hours weekly.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Board appointment of Kim Tzoumakas, CEO of VytlOne National Pharmacy Services with oncology/pharmacy expertise
  • January 2026Leadership promotions: Rakesh Panda to CIO and Nolan Mariano to Chief People Officer
  • +2 moreTrack every material event for The Oncology Institute, Inc. as it happens. Explore monitoring →
Get alerted when The Oncology Institute, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Integrated Oncology ServicesSpecialty cancer treatment network→Value-Based Oncology NetworksOncology provider network focusing on patient outcomes→Community Oncology GroupsIntegrated healthcare systems offering oncology services→

Compare The Oncology Institute, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

The Oncology Institute, Inc. operates in Healthcare Services - Specialty Oncology / Value-Based Cancer Care. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare Services - Specialty Oncology / Value-Based Cancer Care research →
NEW · MCP server

Ask your AI assistant about The Oncology Institute, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare The Oncology Institute, Inc. and its top competitor on Cyborg Score”
“What did The Oncology Institute, Inc. do this quarter?”
“Is The Oncology Institute, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does The Oncology Institute, Inc. do?+
The Oncology Institute (NASDAQ: TOI), founded in 2007, is advancing oncology by delivering highly specialized, value-based cancer care in the community setting, offering cutting-edge, evidence-based cancer care to a p...
What is The Oncology Institute, Inc.'s Cyborg Score?+
The Oncology Institute, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are The Oncology Institute, Inc.'s main competitors?+
Named competitors include Integrated Oncology Services, Value-Based Oncology Networks, Community Oncology Groups. The full competitive landscape is in the AskCyborg report.
How can I get the full The Oncology Institute, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the The Oncology Institute, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track The Oncology Institute, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.